FMC
40
-10
NOC
45
2
GILD
54
3
NRG
72
-2
UHS
59
-8
KO
50
4
MA
64
4
VRSN
60
3
DRI
58
-2
LEN
59
4
COST
50
-3
RIG
37
2
KR
52
3
CHRW
53
2
ROST
51
-3
GOOG
67
4
LRCX
53
-3
XRX
55
3
NWS
47
2
DNB
66
2
FMC
40
-10
NOC
45
2
GILD
54
3
NRG
72
-2
UHS
59
-8
KO
50
4
MA
64
4
VRSN
60
3
DRI
58
-2
LEN
59
4
COST
50
-3
RIG
37
2
KR
52
3
CHRW
53
2
ROST
51
-3
GOOG
67
4
LRCX
53
-3
XRX
55
3
NWS
47
2
DNB
66
2
Financhill
Back

Phillips 66 Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
42

PSX
Phillips 66

Last Price:
131.03
Seasonality Move:
10.4%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Sell
42
Phillips 66 (PSX) is a Sell

Is Phillips 66 a Buy, Sell or Hold?

  • The current Phillips 66 [PSX] share price is $131.05. The Score for PSX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • PSX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PSX Stock Price Chart

What is Phillips 66's stock price today?

  • The Phillips 66 share price today is $131.05
    The current trend is relatively stagnant and PSX is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

PSX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.03 Sell
Relative Strength Index (14 RSI): 49.36 Sell
Chaikin Money Flow: 892204 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (127.23 - 134.69) Buy
Bollinger Bands (100): (131.94 - 142.6) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

PSX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 130.62 Buy
20-day SMA: 129.88 Buy
50-day SMA: 134.27 Sell
200-day SMA: 141.71 Sell
8-day EMA: 130.24 Buy
20-day EMA: 130.65 Buy
50-day EMA: 133.43 Sell
200-day EMA: 135.42 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Phillips 66 Earnings Growth & PSX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.65 per share, an increase next quarter of $1.39 per share, a decrease this year of $6.91 per share, and an increase next year of $3.75 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Phillips 66 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):